ctrl K

AI Score

Unlock

Monopar Therapeutics Inc. (MNPR)

AI Score

Unlock

39.81

-1.58 (-3.82%)

At close: Mar 28, 2025, 3:59 PM

41.91

5.26%

After-hours: Mar 28, 2025, 04:49 PM EDT

Monopar Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-8.83M	-10.54M	-9.13M	-6.51M	-4.32M	-3.4M	-16.6M	-1.19M	-688.56K
Interest Income	429.04M	21.24K	24.02K	81.9K	98.89K	103.22K	48.26K	7.23K	1.25K
Pretax Income	-8.4M	-10.52M	-9.1M	-6.3M	-4.22M	-3.3M	-16.55M	-1.19M	-687.31K
Net Income	-8.4M	-10.49M	-9.08M	-6.22M	-4.13M	-3.23M	-16.55M	-1.19M	-687.31K
Selling & General & Admin	3.23M	2.95M	2.63M	2.44M	2.36M	1.63M	1.17M	912.47K	587.08K
Research & Development	5.6M	7.59M	6.49M	4.07M	1.97M	1.77M	15.44M	280.36K	101.49K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	14.5M	n/a	n/a
Operating Expenses	8.83M	10.54M	9.13M	6.51M	4.32M	3.4M	16.6M	1.19M	688.56K
Interest Expense	n/a	n/a	n/a	n/a	n/a	103.22K	48.26K	7.23K	n/a
Selling & Marketing Expenses	-3.23B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	8.83M	10.54M	9.13M	6.51M	4.32M	3.4M	16.6M	1.19M	688.56K
Income Tax	n/a	-21.24K	-24.02K	-81.9K	-98.89K	-71.61K	-2.1M	800.00	-688.56K
Shares Outstanding (Basic)	14.51M	12.72M	12.47M	10.96M	10.59M	10.42M	10.42M	10.42M	10.59M
Shares Outstanding (Diluted)	14.51M	12.72M	12.47M	10.96M	10.59M	10.42M	10.42M	10.42M	10.59M
EPS (Basic)	-0.58	-0.83	-0.73	-0.57	-0.39	-0.31	-1.59	-0.11	-0.06
EPS (Diluted)	-0.58	-0.83	-0.73	-0.57	-0.39	-0.31	-1.59	-0.11	-0.06
EBITDA	429.04K	n/a	n/a	n/a	n/a	n/a	-16.55M	8.03K	1.25K
Depreciation & Amortization	8.83M	10.54M	9.13M	6.51M	4.32M	3.33M	2.1M	1.19M	688.56K